"Designing Growth Strategies is in our DNA"

Immunoglobulin Market Size, Share & COVID-19 Impact Analysis, By Route of Administration (Intravenous and Subcutaneous), By Indication (Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Immune Thrombocytopenic Purpura, Multifocal Motor Neuropathy, and Others), By Form (Liquid and Lyophilized), By End-user (Hospitals, Clinics, and Homecare), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI100571

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, by Key Players
    2. Key Industry Developments, Mergers, Acquisitions, etc.
    3. Overview of Regulatory Scenario by Key Regions
    4. Prevalence of Primary Immunodeficiency (PID), for Key Countries, 2022
    5. Impact of COVID-19 on Global Immunoglobulins Market
  5. Global Immunoglobulins Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Immunoglobulins Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Immunoglobulins Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Immunoglobulins Market Analysis, Insights and Forecast, 2019-2030
      1. Market Analysis, Insights and Forecast – By Route of Administration
      2. Intravenous
      3. Subcutaneous
    1. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    2. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    4. Market Analysis, Insights and Forecast – By Country
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Immunoglobulins Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country
      1. Brazil
      2. Mexico
      3. Rest of LATAM
  10. Middle East & Africa Immunoglobulins Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Subcutaneous
    2. Market Analysis, Insights and Forecast – By Indication
      1. Primary Immunodeficiency
      2. Secondary Immunodeficiency
      3. Chronic Inflammatory Demyelinating Polyneuropathy
      4. Guillain-Barré Syndrome
      5. Immune Thrombocytopenic Purpura
      6. Multifocal Motor Neuropathy
      7. Others
    3. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    4. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Clinics
      3. Homecare
    5. Market Analysis, Insights and Forecast – By Country
      1. South Africa
      2. GCC
      3. Rest of MEA
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Shire
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. CSL Behring
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Grifols, S.A.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Kedrion S.p.A
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Octapharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Bio Products Laboratory Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Biotest AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. China Biologic Products Holdings, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. LFB Group
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Shanghai RAAS Blood Products Co., Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  Global Immunoglobulin Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 2:  Global Immunoglobulin Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 3:  Global Immunoglobulin Market Value Share (%), by Indication, 2022 & 2030

Figure 4:  Global Immunoglobulin Market Value Share (%), by Form, 2022 & 2030

Figure 5:  Global Immunoglobulin Market Value Share (%), by End-user, 2022 & 2030

Figure 6:  Global Immunoglobulin Market Value (USD billion), by Region, 2022 & 2030

Figure 7:  North America Immunoglobulin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 8:  North America Immunoglobulin Market Value Share (%), by Route of Administration, 2022

Figure 9:  North America Immunoglobulin Market Value (USD billion), by Indication, 2022 & 2030

Figure 10:  North America Immunoglobulin Market Value Share (%), by Indication, 2022

Figure 11:  North America Immunoglobulin Market Value (USD billion), by Form, 2022 & 2030

Figure 12:  North America Immunoglobulin Market Value Share (%), by Form, 2022

Figure 13:  North America Immunoglobulin Market Value (USD billion), by End-user, 2022 & 2030

Figure 14:  North America Immunoglobulin Market Value Share (%), by End-user, 2022

Figure 15:  North America Immunoglobulin Market Value (USD billion), By Country, 2022 & 2030

Figure 16:  North America Immunoglobulin Market Value Share (%), By Country, 2022

Figure 17:  Europe Immunoglobulin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 18:  Europe Immunoglobulin Market Value Share (%), by Route of Administration, 2022

Figure 19:  Europe Immunoglobulin Market Value (USD billion), by Indication, 2022 & 2030

Figure 20:  Europe Immunoglobulin Market Value Share (%), by Indication, 2022

Figure 21:  Europe Immunoglobulin Market Value (USD billion), by Form, 2022 & 2030

Figure 22:  Europe Immunoglobulin Market Value Share (%), by Form, 2022

Figure 23:  Europe Immunoglobulin Market Value (USD billion), by End-user, 2022 & 2030

Figure 24:  Europe Immunoglobulin Market Value Share (%), by End-user, 2022

Figure 25:  Europe Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 26:  Europe Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2022

Figure 27:  Asia Pacific Immunoglobulin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 28:  Asia Pacific Immunoglobulin Market Value Share (%), by Route of Administration, 2022

Figure 29:  Asia Pacific Immunoglobulin Market Value (USD billion), by Indication, 2022 & 2030

Figure 30:  Asia Pacific Immunoglobulin Market Value Share (%), by Indication, 2022

Figure 31:  Asia Pacific Immunoglobulin Market Value (USD billion), by Form, 2022 & 2030

Figure 32:  Asia Pacific Immunoglobulin Market Value Share (%), by Form, 2022

Figure 33:  Asia Pacific Immunoglobulin Market Value (USD billion), by End-user, 2022 & 2030

Figure 34:  Asia Pacific Immunoglobulin Market Value Share (%), by End-user, 2022

Figure 35:  Asia Pacific Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 36:  Asia Pacific Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2022

Figure 37:  Latin America Immunoglobulin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 38:  Latin America Immunoglobulin Market Value Share (%), by Route of Administration, 2022

Figure 39:  Latin America Immunoglobulin Market Value (USD billion), by Indication, 2022 & 2030

Figure 40:  Latin America Immunoglobulin Market Value Share (%), by Indication, 2022

Figure 41:  Latin America Immunoglobulin Market Value (USD billion), by Form, 2022 & 2030

Figure 42:  Latin America Immunoglobulin Market Value Share (%), by Form, 2022

Figure 43:  Latin America Immunoglobulin Market Value (USD billion), by End-user, 2022 & 2030

Figure 44:  Latin America Immunoglobulin Market Value Share (%), by End-user, 2022

Figure 45:  Latin America Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 46:  Latin America Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2022

Figure 47:  Middle East & Africa Immunoglobulin Market Value (USD billion), by Route of Administration, 2022 & 2030

Figure 48:  Middle East & Africa Immunoglobulin Market Value Share (%), by Route of Administration, 2022

Figure 49:  Middle East & Africa Immunoglobulin Market Value (USD billion), by Indication, 2022 & 2030

Figure 50:  Middle East & Africa Immunoglobulin Market Value Share (%), by Indication, 2022

Figure 51:  Middle East & Africa Immunoglobulin Market Value (USD billion), by Form, 2022 & 2030

Figure 52:  Middle East & Africa Immunoglobulin Market Value Share (%), by Form, 2022

Figure 53:  Middle East & Africa Immunoglobulin Market Value (USD billion), by End-user, 2022 & 2030

Figure 54:  Middle East & Africa Immunoglobulin Market Value Share (%), by End-user, 2022

Figure 55:  Middle East & Africa Immunoglobulin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 56:  Middle East & Africa Immunoglobulin Market Value Share (%), By Country/ Sub-region, 2022

Figure 57:  Global Immunoglobulin Market Share (%), By Company, 2022

Table 1:  Global Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2030

Table 2:  Global Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019–2030

Table 3:  Global Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019–2030

Table 4:  Global Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019–2030

Table 5:  Global Immunoglobulin Market Revenue (USD billion) Forecast, by Region, 2019-2030

Table 6:  North America Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 7:  North America Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 8:  North America Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2030

Table 9:  North America Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 10:  North America Immunoglobulin Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 11:  Europe Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 12:  Europe Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 13:  Europe Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2030

Table 14:  Europe Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 15:  Europe Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 16:  Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 17:  Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 18:  Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2030

Table 19:  Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 20:  Asia Pacific Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 21:  Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 22:  Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 23:  Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2030

Table 24:  Latin America Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 25:  Latin America Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 26:  Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2030

Table 27:  Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by Indication, 2019-2030

Table 28:  Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by Form, 2019-2030

Table 29:  Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, by End-user, 2019-2030

Table 30:  Middle East & Africa Immunoglobulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Booklet
  • Jun, 2023
  • 2022
  • 2019-2021
  • 160

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X